Shahin Behroyan

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when iSpecimen Inc. publishes a filing, an earnings call transcript or a press release.

Get ISPC alerts

About Shahin Behroyan

Shahin Behroyan is recorded as CEO at iSpecimen Inc. (ISPC) since August 26, 2026. iSpecimen Inc. reported in an 8-K filed August 31, 2026 that Shahin Behroyan was appointed Chief Executive Officer, effective August 26, 2026. iSpecimen Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at iSpecimen Inc. includes Katharyn Field (CEO), Robert Bradley Lim (CEO and Board Member), Tracy Curley (CEO and Board Member) and 7 others.

“On August 26, 2026, the Board appointed Shahin Behroyan as Chief Executive Officer of the Company, effective immediately.”

iSpecimen Inc. Form 8-K, filed August 31, 2026 · Read the filing

Affiliation history

iSpecimen Inc. (ISPC)
CEO

SEC 8-K

Current
2026-08-26–present

Company network

iSpecimen Inc.

ISPC

Current role

Diagnostics & Research · Healthcare

CEO

2026-08-26–present

Leadership on record at iSpecimen Inc.

Katharyn Field CEO
Robert Bradley Lim CEO, Board Member
Tracy Curley CEO, Board Member
Andrew L. Ross Chairman
Katherine (Katie) Field Chairman, Board Member
Richard Paolone Chairman, Board Member
Yuying Liang CFO
Anthony Lau Board Member
Arphing (Tommy) Lee Board Member
Avtar Dhaliwal Board Member

Recent activity

Executive change Appointed: Chief Executive Officer iSpecimen Inc. (ISPC)
2026-08-26